NP
PFE icon

Nilsine Partners’s Pfizer PFE Stock Holding History

Nilsine Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
10,400
-1,693
-14% -$44.3K 0.02% 384
2026
Q1 		$324K Buy
12,093
+195
+2% +$5.19K 0.03% 325
2025
Q4 		$296K Sell
11,898
-1,966
-14% -$49.6K 0.03% 329
2025
Q3 		$353K Buy
13,864
+825
+6% +$20.4K 0.03% 311
2025
Q2 		$316K Sell
13,039
-2,166
-14% -$50.5K 0.03% 312
2025
Q1 		$385K Buy
15,205
+3,245
+27% +$84.9K 0.04% 265
2024
Q4 		$317K Sell
11,960
-5,368
-31% -$146K 0.03% 308
2024
Q3 		$501K Sell
17,328
-53
-0.3% -$1.55K 0.07% 228
2024
Q2 		$486K Buy
17,381
+4,197
+32% +$116K 0.07% 226
2024
Q1 		$366K Sell
13,184
-20
-0.2% -$555 0.05% 251
2023
Q4 		$380K Sell
13,204
-566
-4% -$17.1K 0.06% 242
2023
Q3 		$457K Sell
13,770
-985
-7% -$34.8K 0.07% 242
2023
Q2 		$541K Sell
14,755
-3,029
-17% -$118K 0.08% 223
2023
Q1 		$726K Buy
+17,784
New +$768K 0.11% 189

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Nilsine Partners's PFE Position: Q2 2026 in Review

Nilsine Partners reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $44.3K and leaving 10,400 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #384.

Nilsine Partners first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $726K in Q1 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nilsine Partners held 10,400 shares of Pfizer worth $250K as of Q2 2026.
  • Nilsine Partners sold 1,693 Pfizer shares in Q2 2026, an estimated $44.3K.
  • Pfizer made up 0.02% of Nilsine Partners's portfolio in Q2 2026, its #384 holding.
  • Nilsine Partners first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Nilsine Partners's Pfizer position peaked at $726K in Q1 2023.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.